To further demonstrate that activation of Nrf2/ARE pathway by CDDO-MA could be beneficial in a rodent model of 3-NP mediated HD, we employed systemic administration of 3-NP toxicity in Lewis rats [46]. The gene discussed is NFE2L2; the disease is Huntington disease.